What is Pulmonary Fibrosis?

Pulmonary fibrosis is a condition in which the lungs gradually develop scar tissue, making breathing harder over time. While there is currently no cure, pulmonary fibrosis treatment aims to slow the progression of the disease, manage symptoms, and help you maintain the best possible quality of life. Whether you have idiopathic pulmonary fibrosis (IPF) or another form of lung fibrosis, the goal is to support you as fully as possible throughout your treatment journey.

It’s important to know that, although pulmonary fibrosis is a progressive condition, many people benefit significantly from treatment. Therapies are designed to slow the decline in lung function, reduce breathlessness, and help you stay active and independent for as long as possible.

Pulmonary Fibrosis Treatments

The primary treatment for pulmonary fibrosis is antifibrotic therapy, which uses medications to slow the progression of lung scarring. These medicines don’t reverse the scarring that’s already present, but they can slow the progression of the condition. This is why they’re often called disease-modifying treatments – their purpose is to protect your lung function rather than cure the disease.

Alongside antifibrotic medication, some people benefit from palliative care approaches. In pulmonary fibrosis, palliative care doesn’t mean end-of-life care; instead, it focuses on making your symptoms easier to live with and improving your overall comfort and wellbeing. This type of support may include oxygen therapy, specialised breathing exercises, help with managing breathlessness, and practical assistance for daily activities. Many patients find that palliative care adds an extra layer of support that complements their medical treatment.

Understanding the difference between curative and disease-modifying treatments can help set clear and realistic expectations. Although current therapies for IPF and other lung fibrosis conditions cannot eliminate the disease, they can make a meaningful difference by slowing its progression and helping you feel more in control of your symptoms.

Before treatment

When you’re first diagnosed with pulmonary fibrosis, it’s completely normal to feel overwhelmed. Treatment can seem complicated at first, but your healthcare team will guide you through each step and help you understand what to expect. Pulmonary fibrosis treatment usually combines several approaches, including antifibrotic medications, pulmonary rehabilitation, and sometimes oxygen therapy, to provide the fullest possible support. These treatments work best together: early diagnosis leads to starting antifibrotic medicines, which then make symptom management easier and help protect your quality of life.

One of the most important things to know is that early treatment truly makes a difference. Research shows that antifibrotic therapy can significantly slow the decline in lung function, often reducing the rate of progression compared to no treatment. Pulmonary fibrosis is a progressive condition, and in many cases, lung scarring can continue even when symptoms feel stable. Because of this, waiting until things get worse may mean losing the chance to slow the disease when treatment is most effective. Patients who start treatment within the first six months of diagnosis usually maintain their lung function longer and remain more independent in their daily activities.

Before treatment begins, you’ll have a detailed assessment. This often includes lung function tests such as FVC and DLCO, which show how well your lungs are working right now. You’ll also have blood tests to check your liver health, as some antifibrotic medicines can affect liver enzymes. Your respiratory consultant will take time to understand your overall health, other medical conditions, and personal preferences so they can tailor your treatment plan. Many patients find the Pulmonary Fibrosis Patient Passport helpful; it’s a tool that helps you keep track of symptoms, questions, and medical information, making appointments easier and more productive.

During treatment

Once your treatment plan is in place, your respiratory consultant will assess whether antifibrotic treatment, such as pirfenidone or nintedanib, is appropriate for you based on your diagnosis, lung function, and overall health. Both medicines slow down lung scarring, but they work differently and have different side-effect profiles. It’s completely normal to have questions or concerns at this stage, and your consultant will support you in understanding how the medication works and what to expect.

Regular monitoring becomes part of your routine during treatment. You’ll have liver function tests every few months and lung function tests roughly twice a year. These check-ins help your consultant ensure the medication is working as intended and allow early management of any side effects. Most side effects can be eased with simple adjustments or supportive treatments, so it’s essential to keep your doctor updated rather than stopping medication on your own.

Alongside medication, your treatment may include oxygen therapy. This can help you stay active and comfortable if your lungs are no longer able to maintain high enough oxygen levels on their own. Some people use oxygen therapy only when exercising or sleeping, while others use it more regularly. Your doctor will guide you on when supplemental oxygen becomes appropriate.

You may also be invited to join a pulmonary rehabilitation programme, which is one of the most helpful parts of treatment for many patients. These programmes last around 6-8 weeks and include gentle exercise, breathing techniques, and education to help you stay active and independent. Many people feel stronger, more confident, and less breathless after completing pulmonary rehab.

Newer research has also shown that treating acid reflux (GERD) may be helpful for some people. Acid reflux can irritate the lungs and may worsen symptoms, so reducing stomach acid is sometimes included in comprehensive care.

Throughout your treatment, staying in close contact with your healthcare team is key. Letting them know how you’re feeling, physically and emotionally, helps them support you better and adjust your treatment when necessary.

After treatment

As you continue living with pulmonary fibrosis, ongoing care becomes an integral part of staying well. Regular follow-up appointments help your consultant monitor your lung function, adjust your medication or oxygen needs, and make sure you’re getting the best possible support. Continuing with the exercise techniques and breathing strategies you learned in pulmonary rehabilitation can help you stay active and maintain your strength.

Avoiding things that can worsen lung scarring is essential, and stopping smoking is one of the most important steps you can take. Smoking accelerates lung damage, so your healthcare team can offer support and resources if you need help quitting. Skipping pulmonary rehabilitation or missing check-ups can also affect how well your treatment works, so staying engaged with your appointments really does make a difference.

Many people experience side effects during treatment, and it’s easy to worry when this happens. Instead of stopping your medication, talk to your doctor as soon as you notice changes. Most side effects can be managed with dose adjustments or supportive treatments, allowing you to continue receiving the full benefit of your medication. If you experience severe or sudden side effects, seek urgent medical advice or attend your nearest A&E.

For some people with more advanced pulmonary fibrosis, a referral to a specialist lung transplant centre may be part of long-term planning. Although the assessment process is detailed and transplantation involves significant risks, it can offer improved survival and quality of life for suitable candidates.

Living with pulmonary fibrosis can be challenging, but with the right treatment plan, early intervention, and strong support from your healthcare team, many people find they can continue to enjoy meaningful routines, maintain independence, and feel more confident managing their lung health.

FAQs

How long do antifibrotic medications take to work? 

Benefits typically become apparent over 6-12 months, as a slowed decline in lung function rather than improvement. The goal is to preserve existing lung function rather than reverse lung scarring.

Can I qualify for a lung transplant with IPF? 

Eligibility often depends on age (commonly under 65–70), overall health, and disease progression despite treatment.

What should I do if I experience side effects from pirfenidone or nintedanib? 

Contact your healthcare team immediately rather than stopping treatment. Dose adjustments, timing changes, or temporary discontinuation often help manage side effects while maintaining treatment benefits.

Is oxygen therapy permanent once started? 

Oxygen needs may fluctuate based on disease progression and activity levels. Some patients use supplemental oxygen only during exercise or sleep, while others require continuous therapy as their lung condition progresses.

Final Thoughts

Pulmonary fibrosis is a serious but manageable condition when diagnosed early and treated effectively. With the right combination of antifibrotic therapy, rehabilitation, and ongoing care, many patients continue to lead active and fulfilling lives.

If you or a loved one has been diagnosed, consulting a qualified respiratory specialist early can make a meaningful difference in long-term outcomes.